The FDA publish their inspection program (somewhere). I beieve it varies product-by-product and I'm not familiar with yr area unfortunately. Some specific items have additional restrictions due to local "sensitivity" reasons.
The FDA also have MOUs (memoranda of Understanding) with certain countries such that they will accept results of inspections done at origin.
In theory, if no MOU, IMEX FDA are rather uninterested in data generated at origin, they treat every input as a random lot unless there is a track record for that importer/specific product/origin. If the latter, sampling density may be increased, to a worst case scenario of 100%.
As per previous post, most import agents are well aware of these factors. It's their job.
Rgds / Charles.C